Abstract
Age-related macular degeneration (AMD) is a progressive eye disease that attacks the macula of the eye, the area responsible for the sharpest central vision, and affects 5% of people aged 65 and older. Current treatment strategies are of limited benefit and only to a minority of people with specific forms of the disease, thus prevention of macular degeneration at an early stage may be a key factor for both managing and reducing the public health burden of this condition. Due to their antioxidant properties and their location in the macula lutea (and therefore also referred to as macular pigments), lutein and zeaxanthin are believed to play a key role in the prevention of AMD by aiding in the filtration of damaging blue light and sunlight. This review will assess the evidence about the relationship of lutein and zeaxanthin to the prevention of AMD.
Keywords: Lutein, zeaxanthin, macular degeneration, eggs, nutrition, elderly, Dietary Lutein, Age-related macular degeneration (AMD), antioxidant properties, macula lutea, age-related diseases, diabetes mellitus, hypertension (HTN), cardiovascular disease (CVD), osteoporosis, chronic lifestyle-related diseases, chronic diseases, AGE-RELATED MACULAR DEGENERATION, optical density (OD), alphacarotene, beta-carotene, beta-cryptoxanthin, lycopene, antioxidants hypothesis, carotenoids, bioavailability, digestion, coronary heart disease (CHD), egg yolks, regular dietary regimen, Macular Pigment Optical Density
Current Nutrition & Food Science
Title: Dietary Lutein and Zeaxanthin in the Prevention of Age-Related Macular Degeneration in the Elderly
Volume: 6 Issue: 3
Author(s): Greenberg I., Kachal Y., Enten R.S. and Shahar D.R.
Affiliation:
Keywords: Lutein, zeaxanthin, macular degeneration, eggs, nutrition, elderly, Dietary Lutein, Age-related macular degeneration (AMD), antioxidant properties, macula lutea, age-related diseases, diabetes mellitus, hypertension (HTN), cardiovascular disease (CVD), osteoporosis, chronic lifestyle-related diseases, chronic diseases, AGE-RELATED MACULAR DEGENERATION, optical density (OD), alphacarotene, beta-carotene, beta-cryptoxanthin, lycopene, antioxidants hypothesis, carotenoids, bioavailability, digestion, coronary heart disease (CHD), egg yolks, regular dietary regimen, Macular Pigment Optical Density
Abstract: Age-related macular degeneration (AMD) is a progressive eye disease that attacks the macula of the eye, the area responsible for the sharpest central vision, and affects 5% of people aged 65 and older. Current treatment strategies are of limited benefit and only to a minority of people with specific forms of the disease, thus prevention of macular degeneration at an early stage may be a key factor for both managing and reducing the public health burden of this condition. Due to their antioxidant properties and their location in the macula lutea (and therefore also referred to as macular pigments), lutein and zeaxanthin are believed to play a key role in the prevention of AMD by aiding in the filtration of damaging blue light and sunlight. This review will assess the evidence about the relationship of lutein and zeaxanthin to the prevention of AMD.
Export Options
About this article
Cite this article as:
I. Greenberg, Y. Kachal, R.S. Enten and D.R. Shahar, Dietary Lutein and Zeaxanthin in the Prevention of Age-Related Macular Degeneration in the Elderly, Current Nutrition & Food Science 2010; 6 (3) . https://dx.doi.org/10.2174/157340110792389118
DOI https://dx.doi.org/10.2174/157340110792389118 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Bioactive compounds, functional foods, metabolism, and health
Nutrition, metabolism, and their intervention strategies have become focal points of interest in the study of metabolic syndrome and health. Bioactive compounds, phytochemicals, and functional foods play crucial roles in modulating metabolic processes and improving human health. Moreover, the composition of the gut microbiome is also believed to be closely ...read more
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Fatty Acids and Herbal Medicine
Current Traditional Medicine Preface (Hot Topic: Medicinal Strategies in the Treatment of Obesity Guest Editor: Akio Inui)
Current Medicinal Chemistry - Central Nervous System Agents Blood Pressure and Vascular Alterations with Growth in Childhood
Current Pharmaceutical Design Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Peripheral Arterial Disease: The Magnitude of the Problem and its Socioeconomic Impact
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD
Current Cardiology Reviews LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Current Pharmaceutical Design Magnetomotive Molecular Nanoprobes
Current Medicinal Chemistry Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
Current Pharmaceutical Design The Study of HFE Genotypes and Its Expression Effect on Iron Status of Iranian Haemochromatosis, Iron Deficiency Anemia Patients, Iron-Taker and Non Iron-Taker Controls
Recent Advances in DNA & Gene Sequences (Discontinued) Immunophilins and Cardiovascular Complications
Current Medicinal Chemistry Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Cardiovascular Disease and Inflammation: Novel Biomarkers of Inflammation and Endothelial Activation
Vascular Disease Prevention (Discontinued) Racial Differences in Gray Matter Integrity by Diffusion Tensor in Black and White Octogenarians
Current Alzheimer Research Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives
Current Pharmaceutical Design Congenital Heart Disease in Non-Diabetic Large-for-Gestational-Age (LGA) Neonates
Cardiovascular & Hematological Disorders-Drug Targets Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology